Genmab — November 2017
-
Vincent Rajkumar@VincentRK : "Dara-VMP vs VMP in newly dx myeloma. I admire the speed & efficiency of the clinical trial enterprise in Europe. It would take 10 years to do this trial here. Too many cooks... The study shows major improvement in Response rate and PFS I favor of Dara VMP. However it won’t affect practice yet. Hardly anyone uses melphalan in frontline treatment. Await Dara-VRd vs VRd. Im sure results will be same-but we will get sense of safety, & hopefully QOL, OS data"
-
AB fik da godt nok solgt ud i luk
-
Ang recepttal i morgen, så henviser jeg til mit indlæg ang estimater på recepttal - http://www.proinvestor.com/?p=debat_1&postid=75982&thread=50&start=
-
Jan har sagt at oktober vil overgå august, som er den bedste måned med 91,4m usd. Så det må være det laveste tal, vi skal kigge efter
-
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind